Stocks and Investing Stocks and Investing
Mon, February 12, 2024

Chris Shibutani Upgraded (UTHR) to Hold and Increased Target to $215 on, Feb 12th, 2024


Published on 2024-10-28 08:54:11 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Upgraded "United Therapeutics Corporation" (UTHR) to Hold and Increased Target from $213 to $215 on, Feb 12th, 2024.

Chris has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Chris's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Chris


  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Decreased Target to $314 on, Thursday, November 2nd, 2023
  • Jessica Fung of "JP Morgan" Maintained at Buy with Increased Target to $294 on, Thursday, November 2nd, 2023
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $308 on, Thursday, November 2nd, 2023

Contributing Sources